SQTS: Difference between revisions

No change in size ,  26 March 2013
m
no edit summary
mNo edit summary
mNo edit summary
Line 19: Line 19:


==Genetic diagnosis==
==Genetic diagnosis==
[[Image:ShortQT_syndrome_mechanism.png|300px|thumb|right]]
[[Image:ShortQT_syndrome_mechanism.svg|300px|thumb|right]]
In a quarter of the patients a mutation is found, predominantly in the KCNH2 gene (SQTS1). This gain-of-function mutation causes an increase in the potassium efflux and, subsequently, to a decrease of the myocyte refractory period. Mutations in the KCNQ1, KCNJ2 and possibly CACNxxx genes are also associated with the SQTS.
In a quarter of the patients a mutation is found, predominantly in the KCNH2 gene (SQTS1). This gain-of-function mutation causes an increase in the potassium efflux and, subsequently, to a decrease of the myocyte refractory period. Mutations in the KCNQ1, KCNJ2 and possibly CACNxxx genes are also associated with the SQTS.